Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher (TMO)
NYSE:TMO
TMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$385.46 - $627.88
Previous CloseN/A
Volume471.20K
Average Volume (3M)2.75M
Market Cap
$184.46B
Enterprise Value$183.26B
Total Cash (Recent Filing)$6.39B
Total Debt (Recent Filing)$35.23B
Price to Earnings (P/E)28.4
Beta0.78
Next Earnings
Oct 22, 2025EPS Estimate
5.51Next Dividend Ex-Date
Sep 15, 2025Dividend Yield0.34%
Share Statistics
EPS (TTM)5.36
Shares Outstanding377,612,120
10 Day Avg. Volume1,990,232
30 Day Avg. Volume2,750,709
Financial Highlights & Ratios
PEG Ratio4.64
Price to Book (P/B)4.01
Price to Sales (P/S)4.63
P/FCF Ratio27.35
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue4.24
Enterprise Value/Gross Profit10.71
Enterprise Value/Ebitda16.08
Forecast
1Y Price Target
$546.74Price Target Upside12.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThermo Fisher reported improved financials for 2Q25, with revenue increasing by 3.0% YoY and adj. EPS declining lightly by 0.2% YoY, both exceeding Bloomberg consensus.
Strategic PositioningThe synergies created by Thermo’s best-in-class service offerings have solidified its position as the partner of choice for the biopharma industry.
Bears Say
Market RiskWeak performance in Chemical Analysis and Electron Microscopy due to low demand in China and A&G.
Regulatory And Market ExposureRisk factors include exposure to biopharma; reliance on government funding and exposure to regulatory markets; considerable global footprint and China exposure; diverse competition across end-markets; acquisition and integration risks; regulatory and safety concerns; and a potential headwind to margins.
Thermo Fisher News
TMO FAQ
What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest stock price was $385.46 and its highest was $627.88 in the past 12 months.
What is Thermo Fisher’s market cap?
Thermo Fisher’s market cap is $184.46B.
When is Thermo Fisher’s upcoming earnings report date?
Thermo Fisher’s upcoming earnings report date is Oct 22, 2025 which is in 55 days.
How were Thermo Fisher’s earnings last quarter?
Thermo Fisher released its earnings results on Jul 23, 2025. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.226 by $0.134.
Is Thermo Fisher overvalued?
According to Wall Street analysts Thermo Fisher’s price is currently Undervalued.
Does Thermo Fisher pay dividends?
Thermo Fisher pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 0.34%. See more information on Thermo Fisher dividends here
What is Thermo Fisher’s EPS estimate?
Thermo Fisher’s EPS estimate is 5.51.
How many shares outstanding does Thermo Fisher have?
Thermo Fisher has 377,612,120 shares outstanding.
What happened to Thermo Fisher’s price movement after its last earnings report?
Thermo Fisher reported an EPS of $5.36 in its last earnings report, beating expectations of $5.226. Following the earnings report the stock price went up 9.141%.
Which hedge fund is a major shareholder of Thermo Fisher?
Currently, no hedge funds are holding shares in TMO
Thermo Fisher Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$546.74 (12.01% Upside)
$546.74 (12.01% Upside)
Blogger Sentiment
Bullish
TMO Sentiment 77%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.3%
Last 30 Days ▲ 3.2%
Last 30 Days ▲ 3.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.07%
12-Months-Change
Fundamentals
Return on Equity
13.44%
Trailing 12-Months
Asset Growth
2.78%
Trailing 12-Months
Company Description
Thermo Fisher
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted Thermo Fisher's strong operational performance, driven by growth in the pharma and biotech segments, successful product launches, and strategic partnerships. However, challenges in academia, government, and the China market, along with tariff impacts, presented notable headwinds.View all TMO earnings summariesTMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
TMO Stock 12 Month Forecast
Average Price Target
$546.74
▲(12.01% Upside)
Technical Analysis
Ownership Overview
0.12% Insiders
23.88% Mutual Funds
27.27% Other Institutional Investors
29.20% Public Companies and Individual Investors